NeuroFore

Private

St. Louis, MissouriHealthcare & Life Scienceshttp://neurofore.com/

Last Round

Grant

Apr 15, 2026

Total Funding Raised

$37,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

NeuroFore is a biotechnology company that is developing a revolutionary AI-based diagnostic application for the early diagnosis of Parkinson's disease.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Devices, Healthcare Analytics, Biotechnology

Business Model

B2B

Customer Profile

Government Contracts, Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

Parkinson's diagnosisAI diagnosticsearly disease detectionmedical AInon-motor symptomsneurotechmedtechmedical devicepredictive diagnosticsdiagnostic softwareclinical decision supportneurodegenerative diseasebiotechFDA De Novomovement disorders

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NeuroFore Comps

Public and private peers based on sector, stage, and business model.

NeuroFore comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

NeuroFore Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Apr 15, 2026
Grant	Nov 19, 2025

View all Funding Rounds

NeuroFore Investors

Notable investors and investment history

NeuroFore investors
Investor	Rounds
Skandalaris Center for Interdisciplinary Innovation and Entrepreneurship	Grant
Sling Health STL	Accelerator

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Apr 15, 2026
$25K grant from Skandalaris Center for Interdisciplinary Innovation and Entrepreneurship.
Nov 19, 2025
$10K grant received from Skandalaris Center.

View all signals

NeuroFore Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

NeuroFore Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NeuroFore's valuation, stock price, and market status.

Firmographic Details

HeadquartersSt. Louis, Missouri

Year FoundedN/A

Last FundingApr 15, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.